Initial treatment patterns over time for anaplastic oligodendroglial tumors. - Wikidata - awgldk - TriplyDB

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

http://www.wikidata.org/entity/Q30419123

about

Recursive partitioning analysis of prognostic variables in newly diagnosed anaplastic oligodendroglial tumors Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.The future of high-grade glioma: Where we are and where are we going.Accuracy of percentage of signal intensity recovery and relative cerebral blood volume derived from dynamic susceptibility-weighted, contrast-enhanced MRI in the preoperative diagnosis of cerebral tumours Indications for Treatment: Is Observation or Chemotherapy Alone a Reasonable Approach in the Management of Low-Grade Gliomas?Deferred radiotherapy and upfront procarbazine-ACNU-vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade.Diagnostic and prognostic markers in gliomas - an update.Anaplastic glioma: current treatment and management.Diagnostic, prognostic and predictive relevance of molecular markers in gliomas.Procarbazine, lomustine and vincristine or temozolomide: which is the better regimen?Anaplastic oligodendroglioma: a new treatment paradigm and current controversies.PCV for anaplastic oligodendrogliomas: back to the future or a step backwards? A point/counterpoint discussion.A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13-12.Response to Weltman and Fleury Malheiros, re Lassman et al.Current Management of Adult Diffuse Infiltrative Low Grade Gliomas.Success at last: a molecular factor that informs treatment.Pattern of care of anaplastic oligodendroglioma and oligoastrocytoma in a Korean population: the Korean Radiation Oncology Group study 13-12.Chemoradiation for anaplastic oligodendrogliomas: clinical outcomes and prognostic value of molecular markers.Current therapeutic approaches to diffuse grade II and III gliomas.

P2860

Q30370204-E6E76D6A-D32E-4193-BE66-ED1AA9919848 Q30542081-5214F315-D1A2-45BF-B391-017485E3AC38 Q35114090-4DD1ABA9-1333-4E9D-8BD3-2A50AFA32DB1 Q35811181-EB024E5C-09F0-43B5-B35D-345E5A39D0DF Q36037100-12CD69D5-8B34-4B29-BE37-4B4E6AF539A6 Q37429161-906A7D16-6C46-4ABF-B2E8-2C002C3B7C0E Q38070698-B42A6BD7-B93A-4E67-94B6-A9394B0880DB Q38456018-9E76BCBB-9ABC-4F9B-AB75-DF2ADFFACD1E Q38461565-F7DBE2E8-4D1B-4201-8051-488246F114C8 Q38626948-744FC1A4-6C6D-4854-BF88-AB480B67C5AB Q39373950-27BD50C0-FD80-4B67-A77B-B893B2AB1A67 Q39453835-8585E880-6989-4515-AA7C-7DE72B323029 Q40572125-3CEC5573-D017-4758-B766-0D1ACD509556 Q45975426-3A94213E-BC76-4E66-8787-562268721633 Q47860829-7BB87D30-D6AF-4BD0-AB73-9EF700DEEDCF Q48250296-96D728FB-4672-45D6-80A9-F15B8D5F38F9 Q48457980-5A71DE9A-6236-4E8E-A07F-306941ACDEC0 Q48910170-BD75948C-9061-4756-AB2E-CEFDA5930E3F Q49317056-668B3F7A-667A-4C62-BC8D-CE3EC0331F80

P2860

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

http://www.wikidata.org/entity/Q30419123

description

2012 nî lūn-bûn

@nan

2012 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@ast

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@en

type

label

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@ast

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@en

prefLabel

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@ast

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@en

P1433

Q30419123-03C7119B-8272-43C2-BE6F-FB85696462BC

P1476

Q30419123-1F587232-D36C-4967-AD47-E4FAFBB66B74

P2093

Q30419123-1963A250-B97A-4798-AA99-834DD86844DB

Q30419123-1C0B4BF3-9950-4A6A-82B0-899BE5D8E90B

Q30419123-1DA2768A-73AD-497E-821D-B8D42AC0FCE1

Q30419123-20FC61A6-DDE9-4E48-ABDA-15FEFB22BC81

Q30419123-21C5B0B0-9AE4-4B52-A40D-4C68B3E0B65B

Q30419123-225BC594-BA41-4118-9777-77129FB922C2

Q30419123-33C06DA8-2743-41C0-BE53-D81F84EA0718

Q30419123-45C09FCC-FD0C-4BB8-AB50-470733DF4868

Q30419123-59E7F23F-AC55-4C35-AF9A-8C3678D0AB5C

Q30419123-5AD8F218-DC26-40A8-AE0F-D048BFD1705F

P2860

Q30419123-234FA019-07A4-4451-AB0C-9B80F075D37D

Q30419123-23C4F849-D307-4DF1-96B8-4246E98557CC

Q30419123-61AC42BE-BE03-4C7C-B860-16DA86CBA573

Q30419123-6699AC42-F0AC-4612-ACE4-19E72EFD8363

Q30419123-6A39E0F2-DE47-4920-96D3-56F8611DCE82

Q30419123-729ABA34-E6FA-4719-918F-B474F950D607

Q30419123-92E9F9B3-A010-45C2-AA44-9B0B73E2C787

Q30419123-AB36DB23-5D77-47C5-9445-28D6D67DF0FC

Q30419123-AE981AC8-7B10-4B1D-8EBC-8CED50D3543D

Q30419123-AF27B524-A07C-4F9B-87AA-59E0C193FB34

P304

Q30419123-26075381-3BC1-4EC6-BAAC-A8F58B3817A7

P31

Q30419123-ED584232-127B-4A87-A963-1A0FA89ACA90

P356

Q30419123-2E802B06-8E72-4552-9C62-1B6869D99811

P433

Q30419123-858E4321-35E9-4D28-99DA-B006BD4242C9

P478

Q30419123-C527F26E-A1EE-472A-BDB9-7CA5E6FD4BE3

P577

Q30419123-2DB7826B-59B5-4879-9159-0BB2D8DAABF2

P5875

Q30419123-C6D23641-6B88-42DD-889E-3054C9D9E593

P698

Q30419123-A40938E5-FC58-4448-9AEB-3C6DEBD5306E

P921

Q30419123-0F58C6DE-5752-4A14-AC60-0C56819E8E38

P932

Q30419123-BFA903CC-5A76-4CAE-A60E-55F59F8A1676

P356

P1433

P1476

Initial treatment patterns over time for anaplastic oligodendroglial tumors.

@en

P2093

Andreana L Rivera

http://www.w3.org/2001/XMLSchema#string

Andrew B Lassman

http://www.w3.org/2001/XMLSchema#string

April F Eichler

http://www.w3.org/2001/XMLSchema#string

Barbara J Fisher

http://www.w3.org/2001/XMLSchema#string

Brandon G Rocque

http://www.w3.org/2001/XMLSchema#string

David N Louis

http://www.w3.org/2001/XMLSchema#string

David Schiff

http://www.w3.org/2001/XMLSchema#string

Fabio M Iwamoto

http://www.w3.org/2001/XMLSchema#string

Francois G Kamar

http://www.w3.org/2001/XMLSchema#string

Gloria B Roldán Urgoiti

http://www.w3.org/2001/XMLSchema#string

P2860

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

International retrospective study of over 1000 adults with anaplastic oligodendroglial tumors

Survey of treatment recommendations for anaplastic oligodendroglioma

Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group.

Adjuvant procarbazine, lomustine, and vincristine improves progression-free survival but not overall survival in newly diagnosed anaplastic oligodendrogliomas and oligoastrocytomas: a randomized European Organisation for Research and Treatment of Ca

IDH1 and IDH2 mutations are prognostic but not predictive for outcome in anaplastic oligodendroglial tumors: a report of the European Organization for Research and Treatment of Cancer Brain Tumor Group.

Phase II trial of preirradiation and concurrent temozolomide in patients with newly diagnosed anaplastic oligodendrogliomas and mixed anaplastic oligoastrocytomas: RTOG BR0131

Medical oncology: Optimizing chemotherapy and radiotherapy for anaplastic glioma.

NOA-04 randomized phase III trial of sequential radiochemotherapy of anaplastic glioma with procarbazine, lomustine, and vincristine or temozolomide.

Anaplastic glioma: how to prognosticate outcome and choose a treatment strategy. [corrected].

P304

761-767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NEUONC/NOS065

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2012-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

225095672

http://www.w3.org/2001/XMLSchema#string

P698

22661585

http://www.w3.org/2001/XMLSchema#string

P921

oligodendrocyte

P932

3367843

http://www.w3.org/2001/XMLSchema#string